News
Diabetes and weight loss drugs could help treat a type of liver disease. Here's what to know.
A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also help people with a type of liver disease. CBS News contributor Dr. Celine Gounder explains the findings.
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...
Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.
More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Kyle Richards and Mauricio Umansky's daughter, Sophia Umansky, posted a TikTok and revealed that she’s been taking Mounjaro for around four months. She explained that she believes the weight-loss drug ...
It's claimed drugs like Ozempic could be available after a short consultation at a cost of £9.90 - broadening access to these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback